Adam D. Pfefferle

1.7k total citations
32 papers, 1.1k citations indexed

About

Adam D. Pfefferle is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Adam D. Pfefferle has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Adam D. Pfefferle's work include Cancer Cells and Metastasis (13 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer-related Molecular Pathways (7 papers). Adam D. Pfefferle is often cited by papers focused on Cancer Cells and Metastasis (13 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer-related Molecular Pathways (7 papers). Adam D. Pfefferle collaborates with scholars based in United States, Australia and Germany. Adam D. Pfefferle's co-authors include Charles M. Perou, Jeffrey M. Rosen, Jerry Usary, Olivier Fédrigo, Gregory A. Wray, Courtney C. Babbitt, Benjamin T. Spike, Sandra B. Greene, Jelena Knežević and Ivana Petrović and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Adam D. Pfefferle

27 papers receiving 1.1k citations

Peers

Countries citing papers authored by Adam D. Pfefferle

Since Specialization

Citations

This map shows the geographic impact of Adam D. Pfefferle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam D. Pfefferle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam D. Pfefferle more than expected).

Fields of papers citing papers by Adam D. Pfefferle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam D. Pfefferle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam D. Pfefferle. The network helps show where Adam D. Pfefferle may publish in the future.

Co-authorship network of co-authors of Adam D. Pfefferle

This figure shows the co-authorship network connecting the top 25 collaborators of Adam D. Pfefferle. A scholar is included among the top collaborators of Adam D. Pfefferle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam D. Pfefferle. Adam D. Pfefferle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study 2025 ·Gynecologic Oncology ·Victoria Bae‐Jump, Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle, Michele C. Hayward, Joan L. Walker, Andrea R. Hagemann, Steven Waggoner, Roisin E. O’Cearbhaill, Megan McDonald, Mitchell I. Edelson, Paul DiSilvestro, (unknown), (unknown), Ramey D. Littell, Frederick R. Ueland, Heather A. Lankes, Carol Aghajanian	1
2	Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets 2025 ·npj Breast Cancer ·(unknown), Aranzazu Fernández-Martínez, Cheng Fan, Adam D. Pfefferle, Michele C. Hayward, Katherine A. Hoadley, Naim U. Rashid, Sara M. Tolaney, George Somlo, Lisa A. Carey, William M. Sikov, Charles M. Perou	0
3	Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer 2022 ·Scientific Reports ·(unknown), (unknown), Amy L. Olex, (unknown), (unknown), Mohammad A. Alzubi, (unknown), (unknown), (unknown), (unknown), (unknown), Timothy M. Smith, Adam D. Pfefferle, Mikhail G. Dozmorov, J. Chuck Harrell	5
4	Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells 2021 ·Nature Communications ·(unknown), (unknown), Aleata A. Triplett, (unknown), Jonathan H. Shepherd, Adam D. Pfefferle, Hallgeir Rui, Robert D. Cardiff, Charles M. Perou, Kay‐Uwe Wagner	30
5	Oncogenic PI3K Mutations Lead to NF- B-Dependent Cytokine Expression following Growth Factor Deprivation 2020 ·UNC Libraries ·(unknown), (unknown), Adam D. Pfefferle, Albert S. Baldwin, Jessica E. Hutti, Charles M. Perou	0
6	The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor 2019 ·Disease Models & Mechanisms ·Adam D. Pfefferle, David B. Darr, Benjamin C. Calhoun, Kevin R. Mott, Jeffrey M. Rosen, Charles M. Perou	10
7	A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer 2018 ·Breast Cancer Research and Treatment ·Daniel P. Hollern, Cristina M. Contreras, (unknown), Grace O. Silva, Adam D. Pfefferle, Jessie Xiong, David B. Darr, Jerry Usary, Kevin R. Mott, Charles M. Perou	19
8	Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression 2017 ·Oncogene ·Kevin Roarty, Adam D. Pfefferle, Chad J. Creighton, Charles M. Perou, Jeffrey M. Rosen	32
9	Abstract 3306: Wnt pathway dynamics in breast cancer progression 2016 ·Cancer Research ·Kevin Roarty, Adam D. Pfefferle, Chad J. Creighton, Charles M. Perou, Jeffrey M. Rosen	3
10	Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy 2015 ·Breast Cancer Research and Treatment ·Adam D. Pfefferle, Benjamin T. Spike, (unknown), Charles M. Perou	23
11	Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential 2015 ·Oncogene ·Jelena Knežević, Adam D. Pfefferle, Ivana Petrović, Sandra B. Greene, Charles M. Perou, Jeffrey M. Rosen	100
12	Conditional Loss of ErbB3 Delays Mammary Gland Hyperplasia Induced by Mutant PIK3CA without Affecting Mammary Tumor Latency, Gene Expression, or Signaling 2013 ·Cancer Research ·Christian D. Young, Adam D. Pfefferle, Philip Owens, María G. Kuba, Brent N. Rexer, Justin M. Balko, Violeta Sánchez, Hailing Cheng, Charles M. Perou, Jean J. Zhao, Rebecca S. Cook, Carlos L. Arteaga	20
13	Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis 2013 ·Clinical & Experimental Metastasis ·J. Chuck Harrell, Adam D. Pfefferle, (unknown), Aleix Prat, Cheng Fan, Andrey Khramtsov, Olufunmilayo I. Olopade, Melissa A. Troester, Andrew C. Dudley, Charles M. Perou	40
14	Oncogenic PI3K Mutations Lead to NF-κB–Dependent Cytokine Expression following Growth Factor Deprivation 2012 ·Cancer Research ·Jessica E. Hutti, Adam D. Pfefferle, (unknown), (unknown), Charles M. Perou, Albert S. Baldwin	61
15	Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models 2012 ·Clinical Cancer Research ·Patrick J. Roberts, Jerry Usary, David B. Darr, Patrick M. Dillon, Adam D. Pfefferle, Martin C. Whittle, James S. Duncan, Søren M. Johnson, Austin J. Combest, Jian Jin, William C. Zamboni, Gary L. Johnson, Charles M. Perou, Norman E. Sharpless	107
16	Abstract 4875: Human HER2 and PI3K H1047R cooperate to promote mammary tumorigenesis in vivo 2012 ·Cancer Research ·Ariella B. Hanker, María G. Kuba, Violeta Sánchez, Cammie R. Sutton, Adam D. Pfefferle, Justin M. Balko, Charles M. Perou, Rebecca S. Cook, Carlos L. Arteaga	9
17	LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma 2012 ·Cancer Cell ·Wenjin Liu, Kimberly B. Monahan, Adam D. Pfefferle, Takeshi Shimamura, Jessica A. Sorrentino, Keefe T. Chan, David W. Roadcap, David W. Ollila, Nancy E. Thomas, Diego H. Castrillón, C. Ryan Miller, Charles M. Perou, Kwok‐Kin Wong, James E. Bear, Norman E. Sharpless	96
18	A Potential Role for Glucose Transporters in the Evolution of Human Brain Size 2011 ·Brain Behavior and Evolution ·Olivier Fédrigo, Adam D. Pfefferle, Courtney C. Babbitt, Ralph Haygood, Christine E. Wall, Gregory A. Wray	25
19	Comparative expression analysis of the phosphocreatine circuit in extant primates: Implications for human brain evolution 2010 ·Journal of Human Evolution ·Adam D. Pfefferle, Lisa Warner, (unknown), (unknown), Courtney C. Babbitt, Olivier Fédrigo, Gregory A. Wray	20
20	A Pipeline to Determine RT-QPCR Control Genes for Evolutionary Studies: Application to Primate Gene Expression across Multiple Tissues 2010 ·PLoS ONE ·Olivier Fédrigo, Lisa Warner, Adam D. Pfefferle, Courtney C. Babbitt, Peter Cruz‐Gordillo, Gregory A. Wray	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact